POOJA BHANDARI
JACKSON, MS NPI 1063115244
Browse related groups: MS SK Life Science, Inc. All categories
General Payments — all program years on this page
$430.34
- Category: General Payments
- Program years: PY2023–2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $316.44 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.44 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $123.42 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $85.22 | 1 |
| LivaNova USA, Inc. | $77.16 | 3 |
| Acerta Pharma LLC | $15.48 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.16 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1110508948 | AstraZeneca Pharmaceuticals LP | $15.48 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137488002 | Takeda Pharmaceuticals U.S.A., Inc. | $15.16 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144442948 | CATALYST PHARMACEUTICALS, INC. | $85.22 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152787663 | LivaNova USA, Inc. | $23.05 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152787683 | LivaNova USA, Inc. | $16.32 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152787715 | LivaNova USA, Inc. | $37.79 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154137376 | SK Life Science, Inc. | $123.42 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.